The present study showed that the expression of NGAL and KIM-1 may play a role in gastric carcinogenesis and can be useful as a biomarker in the diagnosis and tracking of gastric cancer, which in turn can allow for more accurate identification of patients at risk. The gene discussed is LCN2; the disease is gastric cancer.